MeDiC  |  Metabolic Disorders and Complications Program

Our Researchers

The Metabolic Disorders and Complications Program (MeDiC) brings together a team of outstanding research scientists who share the goal of developing new diagnostic tools, treatments and health policies for obesity, diabetes and osteoporosis, along with their complications, including kidney failure, heart disease, fatty liver/cirrhosis, dementia and stroke.

More than one in three Canadians are affected by common and chronic metabolic disorders. The MeDiC Program unites multidisciplinary researchers to study these problems in both adults and children. Each member of the MeDiC program is also affiliated with at least one of the research centres at the Research Institute of the McGill University Health Centre: the Centre for Translational Biology, the Centre for Innovative Medicine and the Centre for Outcomes Research and Evaluation.

To learn more about the MeDiC program, visit our Events, News and Contact Us pages.

Filters icon icon

Displaying 53 result(s).

Ahsan Alam, MDCM, M.Sc.

Chronic kidney disease

acute kidney injury

autosomal dominant polycystic kidney disease

kidney transplantation

clinical epidemiology

Sero Andonian, MD

Endourology

kidney stone disease

radiation safety

medical education

minimally invasive surgery

Alexis Baass, MD, M.Sc.

Lipidology

cardiovascular risk

metabolism

clinical biochemistry

cardiovascular prevention

Paul Barré, MD, FRCPC, CSPQ

chronic kidney disease

hemodialysis

metabolic bone disease

polycystic kidney disease

anemia

Andrew Bateman, PhD

Progranulin

neuroprotection

tissue repair

growth factors

cell communication

CTB

Barry Bedell, MD, PhD

Imaging

MRI

PET

image processing

neuropathology

CTB

John Bergeron, D. Phil.

quantitative proteomics

subcellular Fractionation

electron microscopy

systems biology

protein secretion and endocytosis

CTB

David Buckeridge, MD, PhD

biosurveillance

public health

medical informatics

CORE

Sergio Burgos, PhD

nutrition

metabolism

insulin resistance

skeletal muscle

CTB

Stéphanie Chevalier, RD, PhD

nutrition

metabolism

sarcopenia

aging

lung cancer

CTB

Tyler Churchward-Venne, PhD

Skeletal muscle • resistance and endurance exercise • protein and amino acid metabolism • stable isotope tracers • nutrition and muscle health • aging

Andrey Cybulsky, MD

cell injury

glomerulonephritis

phospholipases

protein kinases

stress proteins

CTB

Deborah Da Costa, PhD

Mental health

behavioural medicine

e-health

pregnancy/postpartum

chronic illnesses

CORE

Kaberi Dasgupta, MD, M.Sc.

diabetes prevention

diabetes reversal

diabetes management

physical activity

eating behaviours

CORE

Gustavo Duque, MD, PhD, FRACP, FGSA

osteoporosis • sarcopenia • osteosarcopenia • aging • geriatrics • gerontology • geroscience • bone • muscle • fat

George Fantus, MD, FRCPC

Insulin resistance • tyrosine kinase and phosphatase • glucose metabolism • diabetes complications • oxidative stress

CTB

David Goltzman, MD

calcium and mineral metabolism

hormonal regulation

bone metabolism

osteoporosis

parathyroid disorders

CTB

Steven Grover, MD

clinical epidemiology

clinical guidelines

computer modelling

cost effectiveness

health promotion

CORE

Ahmad Haidar, PhD

Type 1 diabetes

clinical research

artificial pancreas systems

automated insulin delivery system

randomized controlled trials

CTB

Bertrand Jean-Claude, M.Sc., PhD

Kinase inhibitors

anti-cancer drugs

pharmacokinetics

molecular modeling

CTB

Maia Kokoeva, PhD

Obesity

diabetes

hypothalamus

leptin receptor

leptin sensing

CTB

Richard Kremer, MD, PhD

vitamin D

parathyroid hormone related peptide (PTHrP)

breast cancer

skeletal metastasis

circulating tumour cells

CTB

Stéphane Laporte, PhD

G protein-coupled receptor

molecular pharmacology

cell imaging

cardiovascular diseases

pre-term birth.

CTB

Louise Larose, PhD

intracellular signaling • adaptor proteins • unfolded protein response • insulin resistance • obesity and diabetes

CTB

Serge Lemay, MD

tyrosine kinase

adaptor proteins

acute kidney injury

cell signaling

CTB

Jun-Li Liu, PhD

CCN5/WISP2

pancreatic islets

growth and development

transgenic mice

knockout mice

CTB

Errol Marliss, MD, FRCPC

Nutrition

metabolism

diabetes

obesity

insulin resistance

CTB

José Morais, MD

protein requirements with aging

muscle protein regulation

insulin resistance

sarcopenia

frailty

CTB

Suzanne Morin, MD, M.Sc., FRCP, FACP

Osteoporosis

fractures

bone mineral density

administrative healthcare databases

atypical femur fractures

CORE

Romina Pace, MD, M.Sc.

Indigenous health

diabetes

cardiovascular risk factors

health services research

database analysis

CORE

Vassilios Papadopoulos, PhD

steroids • neurosteroids • pharmacology • drug discovery • endocrinology

CTB

Steven Paraskevas, MD, PhD

islets of Langerhans

type 1 diabetes

cell death

inflammation

ischemia-reperfusion injury

CTB

Shafaat Rabbani, MD

Breast and prostate cancer

DNA methylation

proteases and growth factors

bone metastasis

cancer progression

CTB

Elham Rahme, PhD

pharmacoepidemiology

drug utilisation

drug adverse events

tumour necrosis factor inhibitors

anticoagulants

CORE

Juan-Andres Rivera, MD

endocrine cancer

neuroendocrine tumors

acromegaly

multidisciplinary teams

Christian Rocheleau, PhD

epidermal growth factor receptor (EGFR)

Ras protein

Caenorhabditis elegans

Rab proteins

vesicular trafficking

CTB

Paul Sabatini, PhD

central nervous system • feeding behaviour • energy expenditure • obesity brainstem • hypothalamus

CTB

Shaifali Sandal, MD, FRCPC

Kidney transplantation

living donor

nephrology

clinical research

CIM

Ruth Sapir-Pichhadze, B.Med.Sc., MD, M.Sc., PhD, FRCPC

kidney transplantation • nephrology • clinical epidemiology • clinical research • histocompatibility

CORE

Hiroaki Sato, MD, PhD

catabolic response to surgery • clinical outcomes • cardiac anesthesia

Thomas Schricker, MD, PhD

catabolic response to surgery

clinical outcomes

perioperative nutrition

Mark Sherman, MD

Hyperlipidemia

diabetes

dyslipidemia

Robert Sladek, MD

genetics

type 2 diabetes

obesity

Rita Suri, MD, M.Sc.

dialysis • frequent dialysis • randomized trials • quality of life • blood pressure • COVID-19

CORE

Tomoko Takano, MD, PhD

nephrotic syndrome

proteinuria

podocytes

Rho-GTPases

cytoskeleton

CTB

Elena Torban, PhD

kidney development

planar cell polarity

cilia formation and ciliophaties

glomerular disease

mouse models of human kidney diseases

CTB

Emilie Trinh, MD, M.Sc.

Nephrology • peritoneal dialysis • home hemodialysis • intensive hemodialysis

George Tsoukas, MD

Endocrinology

GLP-1

diabetes

cardiology

endocrinology

Jeremy Van Raamsdonk, PhD, M.Sc

aging

biological resilience

neurodegeneration

Parkinson's disease

Huntington's disease

CTB

Simon Wing, MD

ubiquitin

muscle wasting

spermatogenesis

cachexia

diabetes

CTB

Jean-François Yale, MD, FRCPC

clinical trials in diabetes

hypoglycemia

intensive management of diabetes

adherence

Explore what the MeDiC Program has to offer